InvestorsHub Logo
Followers 17
Posts 2671
Boards Moderated 0
Alias Born 06/04/2020

Re: None

Friday, 10/01/2021 8:26:16 PM

Friday, October 01, 2021 8:26:16 PM

Post# of 4271
Things are moving quick for this ADMP/Tempol competitor oral option...

"Fauci says FDA will review Merck’s new Covid treatment ‘as quickly as they possibly can"

"The U.S. has agreed to purchase 1.7 million courses of molnupiravir"

"Merck projects that it will have 10 million courses of molnupiravir available by the end of 2021"

https://www.cnbc.com/2021/10/01/fauci-says-fda-will-review-mercks-new-covid-treatment-as-quickly-as-they-possibly-can-.html

but, but, but, but, but 50%. tic toc

.25 isn't a lot of money and 7's aren't lucky. Ignore the noise!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADMP News